← Open Payments lookup

MATTHEW BRAMS: Open Payments

NPI 1639187263 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$249,262 in 236 payments from 13 companies in 2025. Trend: 2023 $246,648 · 2024 $264,631 · 2025 $249,262

Speaker / faculty: $221,038Travel & lodging: $17,511Food & beverage: $5,576Consulting: $5,137
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.77$93,191
Vanda Pharmaceuticals Inc.84$82,691
Teva Pharmaceuticals USA, Inc.28$43,334
E.R. Squibb & Sons, L.L.C.31$29,171
Janssen Pharmaceuticals, Inc2$235
Tris Pharma Inc3$201
Axsome Therapeutics, Inc.2$162
Otsuka Pharmaceutical Development & Commercialization, Inc.1$71
Alkermes, Inc.2$53
ABBVIE INC.2$53

Products named: FANAPT, ABILIFY MAINTENA, REXULTI, AUSTEDO XR, COBENFY, UZEDY, ABILIFY ASIMTUFII, SPRAVATO.

Industry payments across TX — which companies pay providers there.